Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Losing Drug Exports To U.S. As China, S. Korea Exports Grow

This article was originally published in PharmAsia News

Executive Summary

India's pharmaceutical industry may be losing its reputation as a sector immune to financial crises, a reputation that has been attracting foreign investors. A recent study showed drug exports from India to the United States fell by 37 percent between October and February. The decline contradicts expectations that the emphases by several governments on prescribing generics meant prosperity for the highly fragmented Indian industry. Research shows China and South Korea are growing in exports to the United States while India's is in decline. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071585

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel